Ana Pocivavsek

Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury.

Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory.

Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.

Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.

Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor.

Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats.

Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance.

Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.

Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals.

Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.

Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.

Acute Kynurenine Challenge Disrupts Sleep-Wake Architecture and Impairs Contextual Memory in Adult Rats.

Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood.

Basic Neuroscience Illuminates Causal Relationship Between Sleep and Memory: Translating to Schizophrenia.

Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia.

Sex Differences in Hippocampal Memory and Kynurenic Acid Formation Following Acute Sleep Deprivation in Rats.

Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia.

Exercise Your Kynurenines to Fight Depression.